Sea Mild Biotechnology Co., Ltd.(TW:7516)
NT$7.63+0.06 (+3.25%)
TW:7516
Sea Mild Biotechnology Co., Ltd. financials statements
NT$7.63
At close:+0.06 (+3.25%)
Sea Mild Biotechnology Co., Ltd. (7516) Financial Statements
Sea Mild Biotechnology Co., Ltd. Financial Overview
Sea Mild Biotechnology Co., Ltd.'s market cap is currently NT$147.33M. The company's EPS TTM is NT$0.35; its P/E ratio is 21.80; Sea Mild Biotechnology Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 341.94M | NT$ 318.82M | NT$ 257.02M | NT$ 202.65M | NT$ 163.82M |
| Gross Profit | NT$ 89.20M | NT$ 91.28M | NT$ 56.37M | NT$ 28.06M | NT$ 12.95M |
| Operating Income | NT$ 7.41M | NT$ 22.28M | NT$ 4.83M | NT$ -11.98M | NT$ -31.99M |
| EBITDA | NT$ 30.81M | NT$ 53.25M | NT$ 21.58M | NT$ -5.63M | NT$ -20.33M |
| Net Income | NT$ 8.22M | NT$ 31.99M | NT$ 6.19M | NT$ -21.38M | NT$ -52.05M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 99.64M | NT$ 91.69M | NT$ 56.46M | NT$ 47.56M | NT$ 38.95M |
| Total Assets | NT$ 325.92M | NT$ 256.11M | NT$ 190.36M | NT$ 157.69M | NT$ 168.23M |
| Total Debt | NT$ 122.78M | NT$ 69.98M | NT$ 55.04M | NT$ 30.32M | NT$ 31.60M |
| Net Debt | NT$ 33.58M | NT$ -12.97M | NT$ 8.41M | NT$ -10.25M | NT$ -7.34M |
| Total Liabilities | NT$ 215.31M | NT$ 153.71M | NT$ 119.96M | NT$ 93.21M | NT$ 82.41M |
| Stockholders' Equity | NT$ 110.61M | NT$ 102.39M | NT$ 70.41M | NT$ 64.48M | NT$ 85.82M |
| Cash Flow | |||||
| Free Cash Flow | NT$ -8.18M | NT$ 22.82M | NT$ 7.59M | NT$ 12.85M | NT$ -15.80M |
| Operating Cash Flow | NT$ 6.85M | NT$ 34.25M | NT$ 8.84M | NT$ 11.71M | NT$ -12.40M |
| Investing Cash Flow | NT$ -10.57M | NT$ -9.64M | NT$ -13.65M | NT$ -2.31M | NT$ 9.88M |
| Financing Cash Flow | NT$ 10.68M | NT$ 11.71M | NT$ 10.85M | NT$ -9.28M | NT$ -10.61M |
Currency in TWD
